Gastrointestinal Cancer News

Higher levels of anxiety and depression among patients with cancer appeared to be associated with more severe disease-related pain, according to study results scheduled for presentation at Supportive Care in Oncology Symposium.

Cancer-related nonprofit organizations play a crucial role in supporting medical research and patient advocacy, generating nearly $6 billion in revenue annually, according to a study published in Journal of the National Comprehensive Cancer Network.

Over the last 20 years, Helicobacter pylori resistance to clarithromycin — an antibiotic commonly used to treat the infection — has more than doubled in Europe, increasing from 9.9% in 1998 to 21.6% in 2018, according to study findings presented at United European Gastroenterology Week.

A study by the NCI-sponsored SWOG Cancer Research Network showed nearly half of the network’s phase 3 clinical trials influenced clinical care guidelines or new drug approvals.

The combination of atezolizumab and bevacizumab prolonged survival compared with standard-of-care sorafenib for patients with unresectable hepatocellular carcinoma who had not received prior systemic therapy, according to topline data from the phase 3 IMbrave150 study.

A randomized phase 3 trial that evaluated the addition of pegilodecakin to FOLFOX for treatment of metastatic pancreatic cancer failed to meet its primary endpoint of OS, according to the agent’s manufacturer.

Patients with RAS and BRAF wild-type metastatic colorectal cancer appeared to have significantly worse survival outcomes after first-line anti-EGFR-based therapy if they had uncommon molecular alterations of anti-EGFR primary resistance, according to results of an exploratory analysis of the phase 2 VALENTINO trial.

Sex-based disparities remain pervasive in cancer clinical trial participation, according to results of a retrospective meta-analysis published in Journal of the National Cancer Institute.

Colorectal cancer patients who initially presented to primary care with no alarming symptoms had to wait longer for a referral to a specialist, according to recent study findings.

Medical Society of Delaware presented the Tilton Award to Nicholas J. Petrelli, MD, FACS.